Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash University, Parkville, VIC, Australia.
Nat Commun. 2021 Jun 17;12(1):3721. doi: 10.1038/s41467-021-23997-x.
Cytosolic transport is an essential requirement but a major obstacle to efficient delivery of therapeutic peptides, proteins and nucleic acids. Current understanding of cytosolic delivery mechanisms remains limited due to a significant number of conflicting reports, which are compounded by low sensitivity and indirect assays. To resolve this, we develop a highly sensitive Split Luciferase Endosomal Escape Quantification (SLEEQ) assay to probe mechanisms of cytosolic delivery. We apply SLEEQ to evaluate the cytosolic delivery of a range of widely studied cell-penetrating peptides (CPPs) fused to a model protein. We demonstrate that positively charged CPPs enhance cytosolic delivery as a result of increased non-specific cell membrane association, rather than increased endosomal escape efficiency. These findings transform our current understanding of how CPPs increase cytosolic delivery. SLEEQ is a powerful tool that addresses fundamental questions in intracellular drug delivery and will significantly improve the way materials are engineered to increase therapeutic delivery to the cytosol.
细胞质转运是高效递呈治疗性肽、蛋白和核酸的必要条件,但也是主要障碍。由于大量相互矛盾的报告,以及灵敏度低和间接检测,当前对细胞质递呈机制的理解仍然有限。为了解决这个问题,我们开发了一种高灵敏度的 Split Luciferase Endosomal Escape Quantification(SLEEQ)检测方法,以探究细胞质递呈机制。我们将 SLEEQ 应用于评估一系列广泛研究的细胞穿透肽(CPP)与模型蛋白融合后的细胞质递呈情况。我们证明带正电荷的 CPP 通过增加非特异性细胞膜结合来增强细胞质递呈,而不是增加内体逃逸效率。这些发现改变了我们目前对 CPP 如何增加细胞质递呈的理解。SLEEQ 是一种强大的工具,可解决细胞内药物递送中的基本问题,并将极大地改善提高细胞质治疗性递呈的材料设计方式。